What is the appropriate dose and infusion time for tranexamic acid for ruptured ectopic pregnancy?

Comment by InpharmD Researcher

Evidence supporting the use of tranexamic acid (TXA) for ruptured ectopic pregnancy is exclusively derived from case reports, thus there is no consensus regarding optimal dose and infusion time. Despite the differences in patient presentations and underlying causes of ectopic pregnancy, most patients received a single dose of 1 g IV TXA either peri- or intra-operatively and achieved hemostasis along with other bleeding control modalities.

  

PubMed: tranexamic acid ruptured ectopic pregnancy = 2 results (2 relevant); tranexamic acid ectopic pregnancy = 7 results (3 relevant)

Background

A 2019 review of tranexamic acid (TXA) in gynecologic surgery notes that the evidence regarding use of TXA in ectopic pregnancy is exclusively from case reports. In one case (see Table 1), a Jehovah’s Witness patient received 1 g intravenous (IV) TXA intraoperatively. Two other cases have observed its use in cervical ectopic pregnancies, where one patient received 1 g IV TXA in conjunction with intramuscular methotrexate and the other one received two doses of 1 g IV TXA 18 hours apart after removal of a double-balloon cervical ripening catheter. The authors emphasized the lack of robust, conclusive evidence supporting use of TXA for this particular indication. [1], [2], [3]

References:

[1] Zakhari A, Sanders AP, Solnik MJ. Tranexamic acid in gynecologic surgery. Curr Med Res Opin. 2020;36(3):513-520. doi:10.1080/03007995.2019.1708533
[2] Arowojolu AO, Ogunbode OO. Cervical ectopic pregnancy managed with methotrexate and tranexamic acid: A case report. Afr J Med Med Sci. 2014;43(4):361-364.
[3] Zambrano N, Reilly J, Moretti M, Lakhi N. Double Balloon Cervical Ripening Catheter for Control of Massive Hemorrhage in a Cervical Ectopic Pregnancy. Case Rep Obstet Gynecol. 2017;2017:9396075. doi:10.1155/2017/9396075

Literature Review

A search of the published medical literature revealed 4 studies investigating the researchable question:

What is the appropriate dose and infusion time for tranexamic acid for ruptured ectopic pregnancy?

Level of evidence

D - Case reports or unreliable data  Read more→



Please see Tables 1-4 for your response.


 

Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports

Design

Case report

Case presentation

Only the patient in the second case report received tranexamic acid (TXA).

A 35-year-old Nigerian woman in her second pregnancy presented to the emergency room (ER) with PV spotting, with an ultrasound revealing an empty uterus with free fluid and right adnexal mass. After extensive discussion and declining all blood products, the patient agreed to surgery and was given TXA 1 g IV. The ectopic was of significant size, and 1.5 liters of hemoperitoneum was recorded. Cell salvage was again used to minimize blood loss. Ischemic electrocardiogram changes were noted postoperatively, including ST depression consistent with hypoxic damage. Postoperative hemoglobin was 5.2. The patient was discharged 48 hours later on ferrous fumarate twice daily.

Study Author Conclusions

The authors believe that this case review series emphasizes the importance of appropriate management of Jehovah’s Witnesses in the studied units. In both of the above cases, these women were in potentially life-threatening situations. Advances in hematology and pharmaceutical therapy contributed to their survival.

References:

Murphy NC, Hayes NE, Ainle FB, Flood KM. Jehovah's Witness patients presenting with ruptured ectopic pregnancies: two case reports. J Med Case Rep. 2014;8:312. Published 2014 Sep 19. doi:10.1186/1752-1947-8-312

 

Management of severe bleeding in a ruptured extrauterine pregnancy: a theragnostic approach

Design

Case report  

Case presentation

A 37-year-old woman without significant medical history except for implantation of an intrauterine device (IUD) was admitted to the emergency department (ED) with abdominal pain and severe bleeding following a syncopal episode at home. Upon arrival, the patient was hypotensive (75/40 mmHg, 76 bpm) with a hemoglobin (Hb) level of 11.2 g/dL, platelet count of 255 x 103 /mL, and an international normalized ratio (INR) of 1.09. The patient did not adequately respond to fluid resuscitation. Extrauterine rupture was suspected based on the presence of intra-abdominal free fluid and a positive pregnancy test. 

Emergency laparotomy was initiated and blood samples along with laboratory coagulation tests (extrinsic and intrinsic activation) showed decreased clot strength with maximum clot firmness not reaching 2 mm, indicating hypofibrinogenemia. The patient was immediately administered 4 g fibrinogen concentrate and 1 g tranexamic acid. During surgery, her fibrinogen level decreased to 0.17 g/L; she received a total of 1 U red blood cells and approximately 400 mL from cell salvage. A ROTEM analysis performed immediately postsurgery showed correction of coagulopathy. Patient became hemodynamically stable without further bleeding and coagulation parameters 8 hour post-surgery were back to normal (fibrinogen 2.75 g/L). Without other complications, patient was discharged 5 days after admission. 

Study Author Conclusions

Treatment regimen in this case report included administration of tranexamic acid, despite the absence of overt hyperfibrinolysis at ROTEM analysis. A recent study has shown that low-grade fibrinolysis may not be detected by conventional thromboelastometry; therefore, antifibrinolytic supplementation may be appropriate if, as in this case, there is reasonable cause to suspect hyperfibrinolysis (local rather than systemical).

Tranexamic acid has been shown to be a well-tolerated and effective treatment for the management of hemorrhage during pregnancy and can reduce transfusion requirements and maternal morbidity in postpartum hemorrhage. 

References:

Grassetto A, Fullin G, Cerri G, Simioni P, Spiezia L, Maggiolo C. Management of severe bleeding in a ruptured extrauterine pregnancy: a theragnostic approach. Blood Coagul Fibrinolysis. 2014;25(2):176-179. doi:10.1097/MBC.0000000000000010

 

Non-operative treatment of ruptured ectopic pregnancy

Design

Case report

Case presentation

A 20-year-old woman presented with vaginal bleeding and abdominal pain but no fever, dysuria, or vaginal discharge. Urine human chorionic gonadotropin was positive, along with tenderness of the abdomen. Ultrasonography revealed a ruptured tubal pregnancy and blood in the abdomen; she was treated non-operatively with close monitoring. The patient received intravenous liquid therapy, nothing by mouth, and intravenous tranexamic acid 1 g four times daily to prevent bleeding. As the patient was hemodynamically stable with no ongoing evidence of bleeding, it was deemed the patient did not need surgery.

Study Author Conclusions

The case shows that non-operative treatment of a ruptured ectopic pregnancy may be a possible non-invasive treatment option in highly selected patients.
References:

Dalsgaard Jensen T, Penninga L. Non-operative treatment of ruptured ectopic pregnancy. BMJ Case Reports. Published online June 13, 2016:bcr2016215311. doi: 10.1136/bcr-2016-215311

 

Ruptured ectopic pregnancy with APLA syndrome – a case report

Design

Case report

Case presentation

A 32-year-old multigravida patient presented to the emergency department (ED) for sudden onset of severe abdominal pain and drowsiness. The patient was on warfarin 5 mg once daily for the past 9 years. Hypovolemic shock with blood pressure (BP) of 60/45 mmHg lead to a diagnosis of antiphospholipid antibody syndrome. The patient was overdue for 2 weeks and had a history of 5 miscarriages in the past. The patient was sent for emergency laparotomy with a preliminary diagnosis of ruptured ectopic pregnancy. In the perioperative setting, the patient received blood products, volume resuscitation, prophylactic antibiotics, and 1 g of tranexamic acid intravenously. Intraoperative blood loss was approximately 4,100 mL. After postoperative treatment, the patient became stable and was discharged on the post-op day 3.

Study Author Conclusions

To conclude, antiphospholipid syndrome requires a multidisciplinary approach to diagnosis and management. It is an important medical condition manifesting in pregnant women, where use of anticoagulation leads to the dilemma of its perioperative continuation.

References:

Bilal RM, Riaz A, Khan RAS. Ruptured ectopic pregnancy with APLA syndrome – a case report. Anaesthesia, Pain & Intensive Care. Published online January 28, 2019:461-463.